{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:42:13Z","timestamp":1770252133512,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070705"],"award-info":[{"award-number":["82070705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572125"],"award-info":[{"award-number":["82572125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cyto.2026.157116","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:38:43Z","timestamp":1768905523000},"page":"157116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Urinary interleukin-37 as a suggested protective biomarker of renal prognosis in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"199","author":[{"given":"Kai","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2026.157116_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.cyto.2026.157116_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2023.01.005","article-title":"Polycystic kidney disease: novel insights into polycystin function","author":"Luo","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cyto.2026.157116_bb0015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.ajkd.2024.08.008","article-title":"Treatment of autosomal-dominant polycystic kidney disease","volume":"85","author":"Jdiaa","year":"2025","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.cyto.2026.157116_bb0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/ijms26031121","article-title":"Autosomal dominant polycystic kidney disease inflammation biomarkers in the tolvaptan era","volume":"26","author":"Lap\u00e3o","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157116_bb0025","article-title":"Immune microenvironment in autosomal dominant polycystic kidney disease","author":"Xue","year":"2025","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.cyto.2026.157116_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/joim.12214","article-title":"Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease","volume":"276","author":"Su","year":"2014","journal-title":"J. Intern. Med."},{"issue":"9","key":"10.1016\/j.cyto.2026.157116_bb0035","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1681\/ASN.2018010074","article-title":"Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1-deficient mice","volume":"29","author":"Yang","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.cyto.2026.157116_bb0040","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2026.157116_bb0045","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1073\/pnas.1821111116","article-title":"Role for nuclear interleukin-37 in the suppression of innate immunity","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cyto.2026.157116_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108955","article-title":"The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity","volume":"35","author":"Cavalli","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2026.157116_bb0055","doi-asserted-by":"crossref","unstructured":"S L, X P, Y W, et al. IL-37 alleviates intervertebral disc degeneration via the IL-1R8\/NF-\u03baB pathway. Osteoarthr. Cartil. 2023;31(5). doi:https:\/\/doi.org\/10.1016\/j.joca.2023.01.006.","DOI":"10.1016\/j.joca.2023.01.006"},{"issue":"9","key":"10.1016\/j.cyto.2026.157116_bb0060","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/biomedicines12092025","article-title":"Interleukin-37 inhibits interleukin-1\u03b2-induced articular chondrocyte apoptosis by suppressing reactive oxygen species","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"issue":"23","key":"10.1016\/j.cyto.2026.157116_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312878","article-title":"IL-37 isoform a prevents collagen-induced arthritis in mice by modulating the Th17\/Treg balance via IL1R8 receptors","volume":"25","author":"Lyu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cyto.2026.157116_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152382","article-title":"IL-37 alleviates TNF-\u03b1-induced pyroptosis of rheumatoid arthritis fibroblast-like synoviocytes by inhibiting the NF-\u03baB\/GSDMD signaling pathway","volume":"228","author":"Ren","year":"2023","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.cyto.2026.157116_bb0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2014.295","article-title":"IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury","volume":"87","author":"Yang","year":"2015","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.cyto.2026.157116_bb0080","first-page":"351","article-title":"IL37 dampens the IL1\u03b2-induced catabolic status of human OA chondrocytes","volume":"56","author":"van Geffen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.cyto.2026.157116_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jinf.2021.01.019","article-title":"Interleukin-37 as a biomarker of mortality risk in patients with sepsis","volume":"82","author":"Wu","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.cyto.2026.157116_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155468","article-title":"Elevated interleukin-37 associated with tophus and pro-inflammatory mediators in Chinese gout patients","volume":"141","author":"Ding","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2026.157116_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000529460","article-title":"IL-37 ameliorates renal fibrosis by restoring CPT1A-mediated fatty acid oxidation in diabetic kidney disease","volume":"9","author":"Xiong","year":"2023","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.cyto.2026.157116_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2024.04.025","article-title":"Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting","volume":"370","author":"Ma","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.cyto.2026.157116_bb0105","article-title":"Interleukin 37 (IL-37) reduces high glucose-induced inflammation, oxidative stress, and apoptosis of podocytes by inhibiting the STAT3-cyclophilin A (CypA) signaling pathway","volume":"26","author":"Zhang","year":"2020","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.cyto.2026.157116_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.kint.2024.01.014","article-title":"Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease","volume":"105","author":"Yang","year":"2024","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.cyto.2026.157116_bb0115","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.kint.2024.01.027","article-title":"Deciphering interleukin 37\u2019s therapeutic potential: insights into alleviating inflammation in autosomal dominant polycystic kidney disease","volume":"105","author":"Xue","year":"2024","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.cyto.2026.157116_bb0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.kint.2023.12.006","article-title":"Modulating inflammation with interleukin 37 treatment ameliorates murine autosomal dominant polycystic kidney disease","volume":"105","author":"Zylberberg","year":"2024","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cyto.2026.157116_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cyto.2026.157116_bb0130","doi-asserted-by":"crossref","unstructured":"L W, Mi C, Z J, et al. Human regulatory B cells suppress autoimmune disease primarily via interleukin-37. J. Autoimmun. 2025;153. doi:https:\/\/doi.org\/10.1016\/j.jaut.2025.103415.","DOI":"10.1016\/j.jaut.2025.103415"},{"key":"10.1016\/j.cyto.2026.157116_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113597","article-title":"Potential and limitations of IL-37, a cytokine targeted for therapy of systemic lupus erythematosus: a systematic review","volume":"144","author":"Mohamed Thaha","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.cyto.2026.157116_bb0140","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1073\/pnas.1324140111","article-title":"Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses","volume":"111","author":"Bulau","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.cyto.2026.157116_bb0145","article-title":"The promise of tubule biomarkers in kidney disease: a review","volume":"78","author":"Jh","year":"2021","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.cyto.2026.157116_bb0150","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/jpm12040548","article-title":"Emerging biomarkers for early detection of chronic kidney disease","volume":"12","author":"Mizdrak","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.cyto.2026.157116_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-022-04223-6","article-title":"Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis","volume":"26","author":"Pan","year":"2022","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.cyto.2026.157116_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:11Z","timestamp":1770205271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"alternative-id":["S1043466626000116"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157116","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary interleukin-37 as a suggested protective biomarker of renal prognosis in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"157116"}}